UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years

Lancet. 2001 Apr 7;357(9262):1094-6. doi: 10.1016/S0140-6736(00)04310-5.


Extracorporeal membrane oxygenation (ECMO) is a supportive intensive-care technique used for babies with acute respiratory failure. We examined morbidity at age 4 years in surviving children recruited to the UK Collaborative ECMO Trial, and provide long-term data on ECMO support compared with contemporary conventional care. The neonatal ECMO policy resulted in improved survival and a favourable outcome. We therefore advocate the safety and efficacy of this intervention.

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Child, Preschool
  • Cognition
  • Extracorporeal Membrane Oxygenation*
  • Follow-Up Studies
  • Humans
  • Infant Mortality
  • Infant, Newborn
  • Nervous System Diseases / etiology
  • Respiratory Insufficiency / complications
  • Respiratory Insufficiency / mortality
  • Respiratory Insufficiency / therapy*
  • Risk Factors
  • Treatment Outcome